Literature DB >> 9488441

Functional interference of Sp1 and NF-kappaB through the same DNA binding site.

F Hirano1, H Tanaka, Y Hirano, M Hiramoto, H Handa, I Makino, C Scheidereit.   

Abstract

Gene activation by NF-kappaB/Rel transcription factors is modulated by synergistic or antagonistic interactions with other promoter-bound transcription factors. For example, Sp1 sites are often found in NF-kappaB-regulated genes, and Sp1 can activate certain promoters in synergism with NF-kappaB through nonoverlapping binding sites. Here we report that Sp1 acts directly through a subset of NF-kappaB binding sites. The DNA binding affinity of Sp1 to these NF-kappaB sites, as determined by their relative dissociation constants and their relative efficiencies as competitor DNAs or as binding site probes, is in the order of that for a consensus GC box Sp1 site. In contrast, NF-kappaB does not bind to a GC box Sp1 site. Sp1 can activate transcription through immunoglobulin kappa-chain enhancer or P-selectin promoter NF-kappaB sites. p50 homodimers replace Sp1 from the P-selectin promoter by binding site competition and thereby either inhibit basal Sp1-driven expression or, in concert with Bcl-3, stimulate expression. The interaction of Sp1 with NF-kappaB sites thus provides a means to keep an elevated basal expression of NF-kappaB-dependent genes in the absence of activated nuclear NF-kappaB/Rel.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488441      PMCID: PMC108839          DOI: 10.1128/MCB.18.3.1266

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

2.  Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.

Authors:  S Sif; T D Gilmore
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 3.  Transcriptional activation: a complex puzzle with few easy pieces.

Authors:  R Tjian; T Maniatis
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

4.  Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.

Authors:  D Krappmann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.

Authors:  A Ueda; K Okuda; S Ohno; A Shirai; T Igarashi; K Matsunaga; J Fukushima; S Kawamoto; Y Ishigatsubo; T Okubo
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

6.  An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.

Authors:  N D Perkins; A B Agranoff; E Pascal; G J Nabel
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

7.  Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells.

Authors:  A Rökaeus; J A Waschek
Journal:  DNA Cell Biol       Date:  1994-08       Impact factor: 3.311

8.  A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

Authors:  N D Perkins; N L Edwards; C S Duckett; A B Agranoff; R M Schmid; G J Nabel
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

9.  Activation of NF-kappa B in vivo is regulated by multiple phosphorylations.

Authors:  M Naumann; C Scheidereit
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

10.  Sp1-mediated transcriptional activation is repressed by Sp3.

Authors:  G Hagen; S Müller; M Beato; G Suske
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more
  55 in total

1.  Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.

Authors:  S H Lee; X Wang; J DeJong
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

Authors:  F Michel; M Soler-Lopez; C Petosa; P Cramer; U Siebenlist; C W Müller
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

3.  Polymorphism of the human alpha1 immunoglobulin gene 3' enhancer hs1,2 and its relation to gene expression.

Authors:  Y Denizot; E Pinaud; C Aupetit; C Le Morvan; E Magnoux; J C Aldigier; M Cogné
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

4.  Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Ping Lei; Stephen Safe
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

5.  miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.

Authors:  Zheng Xu; Shao-Bo Xiao; Peng Xu; Qian Xie; Lu Cao; Dang Wang; Rui Luo; Yao Zhong; Huan-Chun Chen; Liu-Rong Fang
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

6.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

7.  Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.

Authors:  Sanjit K Dhar; Jitbanjong Tangpong; Luksana Chaiswing; Terry D Oberley; Daret K St Clair
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

8.  Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene.

Authors:  Sanjit K Dhar; Bert C Lynn; Chotiros Daosukho; Daret K St Clair
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

9.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

10.  Nuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells.

Authors:  Yanxia Wang; Min Ding; Sarika Chaudhari; Yanfeng Ding; Joseph Yuan; Dorota Stankowska; Shaoqing He; Raghu Krishnamoorthy; Joseph T Cunningham; Rong Ma
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.